Overall Management > Evaluations and Comparisons


Gliomas


A. Flowers
Management of malignant gliomas at Hartford Hospital: Patterns of care and outcomes
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 464

Nieder C, Grosu AL, Molls M
A comparison of treatment results for recurrent malignant gliomas
Cancer Treat Rev. 2000 Dec; 26(6): 397-409

Glioma Meta-analysis Trialists (GMT) Group
Correspondence to: Dr L A Stewart
Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials
Lancet, Volume 359, Number 9311, 23 March 2002 

Edward G. Shaw, Jeffrey H. Wisoff 
Prospective clinical trials of intracranial low-grade glioma in adults and children
Neuro-Oncology, Volume 5, Number 3,
Jul 2003, Page: 153 -- 160

Whittle IR, Basu N, Grant R, Walker M, Gregor A
Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome
Br J Neurosurg 2002 Aug;16(4):343-7

Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials
J Clin Oncol. 1999 Aug;17(8):2572 (PDF Full Text)


Glioblastoma


Marc C. Chamberlain and Lisa Chalmers
A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma
J Neurooncol. 2006 Oct 4; [Epub ahead of print]
Abstract

Stuart A Grossman, K Carson, Steve Piantadosi, J Fisher
Survival of adults with newly diagnosed glioblastoma multiforme (GBM) treated with experimental agents and delayed radiation therapy (RT) versus experimental agents and immediate radiation: the experience of the NABTT CNS consortium
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No.
282

Wendy F Seiferheld, Minesh P Mehta, John Del Rowe, David MacDonald, Corey Langer, Charles Scott, Walter J Curran, W. K. Alfred Yung
Five years of glioblastoma multiforme (GBM) phase II trials at the radiation therapy oncology group (RTOG)
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No.
281

Reni M, Cozzarini C, Ferreri AJ, Ceresoli GL, Galli L, Bianchi A, Villa E.
A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme
Cancer Invest 2000;18(6):510-5


Metastatic Tumors


Hidefumi Aoyama, MD, PhD; Hiroki Shirato, MD, PhD; Masao Tago, MD, PhD; Keiichi Nakagawa, MD, PhD; Tatsuya Toyoda, MD, PhD; Kazuo Hatano, MD, PhD; Masahiro Kenjyo, MD, PhD; Natsuo Oya, MD, PhD; Saeko Hirota, MD, PhD; Hiroki Shioura, MD, PhD; Etsuo Kunieda, MD, PhD; Taisuke Inomata, MD, PhD; Kazushige Hayakawa, MD, PhD; Norio Katoh, MD; Gen Kobashi, MD, PhD
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
JAMA, Vol. 295 No. 21, June 7, 2006
Abstract | News | News


Tumors


Smith TJ, Hillner BE, Desch CE
Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis
J Natl Cancer Inst 1993 Sep 15;85(18):1460-74


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP